GluCare Health, a Dubai-based hybrid digital therapeutics company focused on diabetes, has become the first provider globally to have met the criteria of value-based practices by fulfilling the International Consortium of Health Outcomes Measurements (ICHOM) certification process.
ICHOM is a not-for-profit founded in 2012 to unlock the potential of value-based health care by defining global Sets of Patient-Centered Outcome Measures and driving the adoption and reporting of these measures worldwide to create better value for all stakeholders.
As of 2022, ICHOM has produced 40 Sets of Patient-Centered Outcome Measures that have been adopted by hundreds of healthcare organizations across the globe.
GluCare Health has re-invented diabetes care from a first-principles basis, combining the virtual digital therapeutic (DTx) with the physical clinic in a seamless patient experience. It incorporates an outcome-based approach to delivering healthcare within its hybrid treatment model and started seeing patients in September 2020.
“At GluCare Health, we actively and continuously manage our patients while transparently reporting our outcomes, it is how we have proven that our model of care works better than traditional care. We know, objectively, that patients we manage are better engaged because we provide them with all the necessary tools to engender sustainable behavior change. We see vastly better outcomes under our platform compared to traditional care and, on average, our patients are well-controlled in as little as 90 days with fewer prescribed medications. Outcome reporting has been a core value at GluCare Health from day 1, and utilizing ICHOM’s reporting standards has been critical in showcasing the power of our platform.”
“We are delighted that GluCare Health has become the first recipient of ICHOM’s Certification. Their dedication to transparency and outcomes in a condition as prevalent and disproportionately costly as diabetes is commendable,” said Ms. Suzanne Gaunt, ICHOM’s President and CEO.